IDEAYA Biosciences Inc
NASDAQ:IDYA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IDEAYA Biosciences Inc
NASDAQ:IDYA
|
US |
|
Stora Enso Oyj
OTC:SEOFF
|
FI |
|
Infosys Ltd
NYSE:INFY
|
IN |
|
B
|
Brinker International Inc
F:BKJ
|
US |
|
A
|
Avantor Inc
SWB:AVG
|
US |
|
R
|
Robert Half International Inc
F:RHJ
|
US |
|
Bloomberry Resorts Corp
OTC:BLBRF
|
PH |
|
I
|
Industrial and Commercial Bank of China Ltd
SWB:ICK
|
CN |
|
P
|
Powertip Image Corp
TPEX:6498
|
TW |
|
A
|
Archrock Inc
F:54E
|
US |
|
T
|
Tung Ho Steel Enterprise Corp
TWSE:2006
|
TW |
|
P
|
Pultegroup Inc
DUS:PU7
|
US |
|
B
|
Best Buy Co Inc
XMUN:BUY
|
US |
|
S
|
Sartorius AG
SWB:SRT3
|
DE |
|
Pareto Bank ASA
LSE:0RI3
|
NO |
|
Maximus International Ltd
BSE:540401
|
IN |
|
Kongsberg Gruppen ASA
F:KOZ1
|
NO |
|
Power Corporation of Canada
TSX:POW
|
CA |
Bankruptcy Probability
IDEAYA Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IDEAYA Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
IDEAYA Biosciences Inc
NASDAQ:IDYA
|
3.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
471.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
217.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
74.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IDEAYA Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IDEAYA Biosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.